Vancity Investment Management Ltd Has $7.63 Million Holdings in CME Group Inc. $CME

Vancity Investment Management Ltd decreased its holdings in CME Group Inc. (NASDAQ:CME) by 10.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 27,949 shares of the financial services provider’s stock after selling 3,218 shares during the quarter. CME Group accounts for approximately 1.0% of Vancity Investment Management Ltd’s investment portfolio, making the stock its 28th biggest holding. Vancity Investment Management Ltd’s holdings in CME Group were worth $7,632,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. West Family Investments Inc. raised its stake in shares of CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the last quarter. Asset Dedication LLC boosted its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its holdings in CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares in the last quarter. Finally, 1248 Management LLC grew its holdings in CME Group by 26.8% during the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after buying an additional 38 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
• Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
• Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
• Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

Insider Transactions at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on CME shares. Morgan Stanley dropped their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday, April 23rd. Weiss Ratings lowered shares of CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, June 11th. JPMorgan Chase & Co. increased their target price on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. The Goldman Sachs Group dropped their price target on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Finally, Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group Stock Performance

Shares of CME Group stock opened at $246.38 on Friday. The business’s fifty day simple moving average is $280.74 and its 200 day simple moving average is $287.50. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $244.56 and a 12 month high of $329.16. The firm has a market capitalization of $89.28 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.21.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the company earned $2.80 EPS. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.1%. CME Group’s dividend payout ratio is presently 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.